The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE
- PMID: 10483012
- DOI: 10.1177/096120339900800606
The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE
Abstract
Objective: To examine the relationship between neuropsychological impairment and antiphospholipid antibody syndrome (aPL syndrome) in patients with systemic lupus erythermatosus (SLE).
Patients: Sixty-nine patients satisfying ACR criteria were studied. Sixteen patients with the aPL syndrome and 53 patients without the syndrome were subjected to eight neuropsychological tests, a physical examination and serological investigations. No patients with other pathology, known to cause acute or chronic impairment of neuropsychological function, were included. Sixty-five underwent MRI scans.
Results: There were no significant differences in age, level of education, incidence of hypertension or disease activity in the two groups. Pearson's correlation coefficients revealed a significant negative correlation with duration of disease in six out of eight tests in the aPL positive group and one out of eight in the aPL negative group. This suggests that aPL syndrome may be involved in the psychological impairment in SLE patients. A larger cohort needs to be studied to confirm this observation.
Similar articles
-
Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.Clin Exp Rheumatol. 2014 Jan-Feb;32(1):34-40. Epub 2013 Sep 10. Clin Exp Rheumatol. 2014. PMID: 24021640
-
The role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupus erythematosus.Lupus. 2015 Jul;24(8):875-9. doi: 10.1177/0961203315572717. Epub 2015 Feb 18. Lupus. 2015. PMID: 25697771
-
Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.J Rheumatol. 1995 Oct;22(10):1899-906. J Rheumatol. 1995. PMID: 8991989
-
[Clinical significance of antiphospholipid antibody in pediatric patients and review of literature].Zhonghua Er Ke Za Zhi. 2004 Aug;42(8):571-3. Zhonghua Er Ke Za Zhi. 2004. PMID: 15347440 Review. Chinese.
-
Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies.J Rheumatol. 1998 Mar;25(3):589-92. J Rheumatol. 1998. PMID: 9517786 Review.
Cited by
-
Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.Ann Rheum Dis. 2005 Apr;64(4):620-5. doi: 10.1136/ard.2004.025528. Ann Rheum Dis. 2005. PMID: 15769918 Free PMC article. Clinical Trial.
-
Cognitive dysfunction and associated neuroimaging biomarkers in antiphospholipid syndrome: a systematic review.Rheumatology (Oxford). 2021 Dec 24;61(1):24-41. doi: 10.1093/rheumatology/keab452. Rheumatology (Oxford). 2021. PMID: 34003972 Free PMC article.
-
Pregnancy in systemic lupus erythematosus: a retrospective study from a developing community.Clin Rheumatol. 2008 May;27(5):577-80. doi: 10.1007/s10067-007-0749-0. Epub 2007 Oct 2. Clin Rheumatol. 2008. PMID: 17909740
-
Biomarkers for CNS involvement in pediatric lupus.Biomark Med. 2015;9(6):545-58. doi: 10.2217/bmm.15.26. Biomark Med. 2015. PMID: 26079959 Free PMC article. Review.
-
Intraindividual Change in Cognitive Function Among Adults With Systemic Lupus Erythematosus: A Markov Analysis Over 7 Years.ACR Open Rheumatol. 2023 Mar;5(3):124-131. doi: 10.1002/acr2.11529. Epub 2023 Jan 27. ACR Open Rheumatol. 2023. PMID: 36705542 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical